Back
Berkshire Hathaway Vs. Akero Therapeutics Industry Stock Comparison
Sell
35
BRK.A
Berkshire Hathaway
Last Price:
545,790.06
Seasonality Move:
4.69%
Buy
55
AKRO
Akero Therapeutics
Last Price:
16.62
Seasonality Move:
-0.92%
Sell
35
Berkshire Hathaway (BRK.A)
is a Sell
Is Berkshire Hathaway a Buy, Sell or Hold?
- The current Berkshire Hathaway [BRK.A] share price is $543,905.00. The Score for BRK.A is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- BRK.A is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $16.66. The Score for AKRO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BRK.A Stock Price Chart
What is Berkshire Hathaway's stock price today?
-
The Berkshire Hathaway share price today is $543,905.00
The current trend is moderately bullish and BRK.A is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $16.66
The current trend is relatively stagnant and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
BRK.A Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5777.21 | Buy |
Relative Strength Index (14 RSI): | 58.88 | Buy |
Chaikin Money Flow: | -6726 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (532703.32 - 532729.32) | Buy |
Bollinger Bands (100): | (535513.45 - 535539.45) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.3 | Sell |
Relative Strength Index (14 RSI): | 46.26 | Sell |
Chaikin Money Flow: | -560846 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.77 - 16.11) | Buy |
Bollinger Bands (100): | (19.33 - 50.89) | Sell |
BRK.A Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 547111.26 | Sell |
20-day SMA: | 538055.91 | Buy |
50-day SMA: | 531169.83 | Buy |
200-day SMA: | 511278.11 | Buy |
8-day EMA: | 545288.12 | Sell |
20-day EMA: | 539254.52 | Buy |
50-day EMA: | 534501.03 | Buy |
200-day EMA: | 514179.64 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.24 | Buy |
20-day SMA: | 15.13 | Buy |
50-day SMA: | 23.61 | Sell |
200-day SMA: | 39.89 | Sell |
8-day EMA: | 16.09 | Buy |
20-day EMA: | 16.19 | Buy |
50-day EMA: | 22.53 | Sell |
200-day EMA: | 34.98 | Sell |
Berkshire Hathaway Earnings Growth & BRK.A Earnings Dates
- Analysts estimate an earnings increase this quarter of $234.59 per share, a decrease next quarter of $0.00 per share, an increase this year of $2,685.29 per share, and an increase next year of $60.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.77 per share.
Berkshire Hathaway Technical Analysis
Nov 15 | Nov 16 | Nov 17 | Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 16 | 17 | 20 | 21 | 22 | 24 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Nov 15 | Nov 16 | Nov 17 | Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 16 | 17 | 20 | 21 | 22 | 24 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |